Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tcf7
|
ENSMUSG00000000782.9 | transcription factor 7, T cell specific |
Tcf7l2
|
ENSMUSG00000024985.12 | transcription factor 7 like 2, T cell specific, HMG box |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_52262110_52262261 | Tcf7 | 12692 | 0.122429 | -0.35 | 8.3e-03 | Click! |
chr11_52268551_52268759 | Tcf7 | 6222 | 0.140202 | -0.32 | 1.7e-02 | Click! |
chr11_52257470_52257627 | Tcf7 | 17329 | 0.113303 | -0.28 | 3.8e-02 | Click! |
chr11_52273418_52273583 | Tcf7 | 1377 | 0.317264 | -0.23 | 9.6e-02 | Click! |
chr11_52273199_52273355 | Tcf7 | 1600 | 0.278622 | -0.19 | 1.7e-01 | Click! |
chr19_55643696_55643873 | Tcf7l2 | 98036 | 0.083130 | -0.65 | 8.8e-08 | Click! |
chr19_55896626_55897001 | Tcf7l2 | 1151 | 0.594974 | 0.58 | 2.7e-06 | Click! |
chr19_55750189_55750340 | Tcf7l2 | 7419 | 0.301067 | 0.58 | 4.2e-06 | Click! |
chr19_55788297_55788448 | Tcf7l2 | 45527 | 0.167691 | 0.56 | 8.5e-06 | Click! |
chr19_55877412_55877563 | Tcf7l2 | 15865 | 0.231196 | 0.53 | 2.9e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_70484969_70485278 | 13.06 |
Gm29783 |
predicted gene, 29783 |
20125 |
0.19 |
chr4_98106960_98107306 | 11.68 |
Gm12691 |
predicted gene 12691 |
39466 |
0.19 |
chr16_46848064_46848427 | 9.46 |
Gm6912 |
predicted gene 6912 |
225953 |
0.02 |
chr10_37378360_37378791 | 9.43 |
Gm26535 |
predicted gene, 26535 |
41089 |
0.18 |
chr13_78451442_78451612 | 9.12 |
Gm31946 |
predicted gene, 31946 |
24279 |
0.17 |
chr12_117257144_117257627 | 8.86 |
Mir153 |
microRNA 153 |
6568 |
0.29 |
chr5_103021116_103021278 | 8.85 |
Mapk10 |
mitogen-activated protein kinase 10 |
5798 |
0.25 |
chr11_17750354_17750848 | 8.13 |
Gm12016 |
predicted gene 12016 |
111418 |
0.07 |
chr15_44836696_44836899 | 8.04 |
A930017M01Rik |
RIKEN cDNA A930017M01 gene |
44622 |
0.14 |
chr12_3236518_3237725 | 7.80 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr4_39344820_39345025 | 7.63 |
Gm23607 |
predicted gene, 23607 |
49459 |
0.14 |
chr10_125922069_125922223 | 7.53 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
44022 |
0.2 |
chr8_98309689_98309914 | 7.48 |
Gm7192 |
predicted gene 7192 |
85138 |
0.1 |
chr3_131137154_131137340 | 7.28 |
Gm42449 |
predicted gene 42449 |
462 |
0.8 |
chrX_97069900_97070120 | 7.20 |
Pgr15l |
G protein-coupled receptor 15-like |
2586 |
0.32 |
chr10_13107920_13108404 | 7.12 |
Plagl1 |
pleiomorphic adenoma gene-like 1 |
5303 |
0.23 |
chr13_7307078_7307229 | 7.12 |
Gm8725 |
predicted gene 8725 |
649 |
0.82 |
chr1_24240382_24240533 | 7.09 |
Col9a1 |
collagen, type IX, alpha 1 |
10940 |
0.26 |
chr6_58932915_58933165 | 7.08 |
Herc3 |
hect domain and RLD 3 |
25778 |
0.12 |
chr18_83637397_83637618 | 6.98 |
Gm31621 |
predicted gene, 31621 |
419 |
0.84 |
chr1_14570538_14570748 | 6.95 |
Gm9947 |
predicted gene 9947 |
182294 |
0.03 |
chr3_73056881_73057482 | 6.93 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
238 |
0.92 |
chr2_68193092_68193381 | 6.92 |
Stk39 |
serine/threonine kinase 39 |
30090 |
0.21 |
chr2_21010157_21010628 | 6.91 |
Gm13375 |
predicted gene 13375 |
41338 |
0.14 |
chr16_88570261_88570425 | 6.89 |
Cldn8 |
claudin 8 |
7160 |
0.14 |
chr13_34239820_34239971 | 6.89 |
Slc22a23 |
solute carrier family 22, member 23 |
46364 |
0.11 |
chr17_3275020_3275269 | 6.75 |
Gm34035 |
predicted gene, 34035 |
8063 |
0.17 |
chr10_90259200_90259351 | 6.71 |
Gm5780 |
predicted gene 5780 |
124458 |
0.06 |
chr13_113880654_113880846 | 6.69 |
Arl15 |
ADP-ribosylation factor-like 15 |
86128 |
0.07 |
chr11_32963679_32964058 | 6.61 |
Gm26052 |
predicted gene, 26052 |
20431 |
0.16 |
chr5_45278172_45278449 | 6.58 |
Gm43303 |
predicted gene 43303 |
26381 |
0.18 |
chr19_38054215_38055320 | 6.57 |
I830134H01Rik |
RIKEN cDNA I830134H01 gene |
239 |
0.48 |
chr10_3863520_3864007 | 6.52 |
Gm16149 |
predicted gene 16149 |
5844 |
0.21 |
chr6_77243261_77243450 | 6.49 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
433 |
0.89 |
chr1_57608359_57608537 | 6.49 |
Gm17929 |
predicted gene, 17929 |
44397 |
0.15 |
chr13_110127712_110127934 | 6.45 |
Rab3c |
RAB3C, member RAS oncogene family |
152327 |
0.04 |
chr14_123065358_123065532 | 6.43 |
AA536875 |
expressed sequence AA536875 |
22163 |
0.22 |
chr3_62348500_62348904 | 6.43 |
Arhgef26 |
Rho guanine nucleotide exchange factor (GEF) 26 |
7601 |
0.24 |
chr2_66178208_66178542 | 6.41 |
Gm13618 |
predicted gene 13618 |
9461 |
0.18 |
chr1_41274963_41275329 | 6.39 |
4930448I06Rik |
RIKEN cDNA 4930448I06 gene |
93894 |
0.09 |
chr18_27956892_27957222 | 6.38 |
Gm33674 |
predicted gene, 33674 |
147325 |
0.05 |
chrX_101987046_101987197 | 6.38 |
Nhsl2 |
NHS-like 2 |
17923 |
0.15 |
chr18_9216377_9216790 | 6.29 |
Fzd8 |
frizzled class receptor 8 |
4420 |
0.27 |
chr12_95392993_95393151 | 6.28 |
Gm26055 |
predicted gene, 26055 |
14121 |
0.27 |
chr6_141434067_141434222 | 6.23 |
Gm43958 |
predicted gene, 43958 |
8216 |
0.27 |
chr18_86557897_86558048 | 6.23 |
Gm50386 |
predicted gene, 50386 |
43999 |
0.16 |
chr3_134237027_134237200 | 6.22 |
Cxxc4 |
CXXC finger 4 |
293 |
0.85 |
chr13_28811226_28811377 | 6.21 |
Gm17528 |
predicted gene, 17528 |
15822 |
0.19 |
chr13_108494184_108494369 | 6.20 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
44267 |
0.18 |
chr6_77979020_77979189 | 6.18 |
Ctnna2 |
catenin (cadherin associated protein), alpha 2 |
446 |
0.85 |
chr13_90722911_90723084 | 6.15 |
Gm44338 |
predicted gene, 44338 |
37115 |
0.17 |
chr16_7146478_7146815 | 6.15 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
47101 |
0.21 |
chr2_137244112_137244266 | 6.13 |
Gm14055 |
predicted gene 14055 |
44314 |
0.17 |
chr6_144252272_144252483 | 6.12 |
Sox5 |
SRY (sex determining region Y)-box 5 |
42809 |
0.21 |
chr1_73850653_73851025 | 6.11 |
Mir6351 |
microRNA 6351 |
4736 |
0.19 |
chr11_36701198_36701349 | 6.09 |
Gm22127 |
predicted gene, 22127 |
21609 |
0.23 |
chr14_74359714_74359865 | 6.04 |
4933402J15Rik |
RIKEN cDNA 4933402J15 gene |
4262 |
0.28 |
chr3_116399495_116400013 | 6.01 |
Cdc14a |
CDC14 cell division cycle 14A |
5734 |
0.18 |
chr14_110728437_110728588 | 5.99 |
Gm26255 |
predicted gene, 26255 |
3524 |
0.24 |
chr10_121885754_121885914 | 5.97 |
Gm48804 |
predicted gene, 48804 |
53776 |
0.12 |
chr19_25607786_25607984 | 5.93 |
Dmrt3 |
doublesex and mab-3 related transcription factor 3 |
2416 |
0.34 |
chr11_113052633_113053064 | 5.92 |
2610035D17Rik |
RIKEN cDNA 2610035D17 gene |
120229 |
0.06 |
chr3_45385015_45385410 | 5.91 |
Pcdh10 |
protocadherin 10 |
2579 |
0.24 |
chr16_88599560_88599852 | 5.86 |
Gm49688 |
predicted gene, 49688 |
8964 |
0.11 |
chr16_71497162_71497313 | 5.86 |
Gm22797 |
predicted gene, 22797 |
166551 |
0.04 |
chr4_12601586_12601737 | 5.86 |
Gm37985 |
predicted gene, 37985 |
4273 |
0.35 |
chr3_145083052_145083382 | 5.84 |
Clca2 |
chloride channel accessory 2 |
15887 |
0.18 |
chr5_91727647_91727798 | 5.83 |
Trmt112-ps1 |
tRNA methyltransferase 11-2, pseudogene 1 |
10357 |
0.15 |
chr7_130216444_130216595 | 5.79 |
Fgfr2 |
fibroblast growth factor receptor 2 |
12237 |
0.28 |
chr8_36457363_36458468 | 5.79 |
Trmt9b |
tRNA methyltransferase 9B |
267 |
0.92 |
chr6_107711523_107711880 | 5.78 |
4933431M02Rik |
RIKEN cDNA 4933431M02 gene |
83927 |
0.1 |
chr16_77787854_77788233 | 5.78 |
Gm17333 |
predicted gene, 17333 |
58561 |
0.11 |
chr2_4120085_4120427 | 5.75 |
Gm38085 |
predicted gene, 38085 |
16379 |
0.1 |
chr9_91386515_91386786 | 5.74 |
Zic4 |
zinc finger protein of the cerebellum 4 |
4240 |
0.14 |
chr1_81593373_81593581 | 5.69 |
Gm6198 |
predicted gene 6198 |
35994 |
0.2 |
chr10_115505719_115506136 | 5.69 |
Lgr5 |
leucine rich repeat containing G protein coupled receptor 5 |
42848 |
0.14 |
chr13_84757919_84758070 | 5.68 |
Gm26913 |
predicted gene, 26913 |
67053 |
0.14 |
chr3_49757757_49757973 | 5.68 |
Pcdh18 |
protocadherin 18 |
540 |
0.8 |
chr2_136051705_136052005 | 5.67 |
Lamp5 |
lysosomal-associated membrane protein family, member 5 |
384 |
0.88 |
chr16_63016277_63016428 | 5.63 |
Gm18870 |
predicted gene, 18870 |
12914 |
0.25 |
chr12_99009152_99009303 | 5.61 |
Gm47109 |
predicted gene, 47109 |
16218 |
0.16 |
chr8_29978910_29979061 | 5.59 |
Gm45492 |
predicted gene 45492 |
102975 |
0.08 |
chr13_84398867_84399154 | 5.59 |
Gm26927 |
predicted gene, 26927 |
58897 |
0.13 |
chr7_49677256_49677407 | 5.58 |
Dbx1 |
developing brain homeobox 1 |
40482 |
0.17 |
chr13_77868459_77868617 | 5.58 |
Pou5f2 |
POU domain class 5, transcription factor 2 |
156364 |
0.03 |
chr2_141024463_141024624 | 5.56 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
481 |
0.87 |
chr18_16037927_16038695 | 5.55 |
Gm4835 |
predicted pseudogene 4835 |
49943 |
0.17 |
chr9_115029452_115029661 | 5.54 |
Osbpl10 |
oxysterol binding protein-like 10 |
12893 |
0.21 |
chr7_69578972_69579222 | 5.54 |
Gm44535 |
predicted gene 44535 |
611 |
0.76 |
chr10_32870770_32871013 | 5.53 |
Nkain2 |
Na+/K+ transporting ATPase interacting 2 |
18805 |
0.25 |
chr11_42421196_42421364 | 5.52 |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
1 |
0.99 |
chr13_68997784_68997935 | 5.50 |
Gm48593 |
predicted gene, 48593 |
160 |
0.89 |
chr4_65238564_65239062 | 5.49 |
Pappa |
pregnancy-associated plasma protein A |
114639 |
0.07 |
chr8_113917431_113917666 | 5.48 |
Adamts18 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18 |
68810 |
0.13 |
chr1_42691558_42691883 | 5.44 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
1373 |
0.31 |
chr14_105333832_105334008 | 5.42 |
Ndfip2 |
Nedd4 family interacting protein 2 |
39374 |
0.13 |
chr7_58442652_58442805 | 5.39 |
Gm44852 |
predicted gene 44852 |
75434 |
0.1 |
chrX_71701215_71701398 | 5.38 |
Gm14723 |
predicted gene 14723 |
26351 |
0.18 |
chr1_78167977_78168321 | 5.38 |
Pax3 |
paired box 3 |
28689 |
0.2 |
chr1_97622458_97622872 | 5.37 |
AC099860.1 |
proline rich protein BstNI subfamily 4 (PRB4), pseudogene |
38166 |
0.15 |
chr7_63753115_63753482 | 5.37 |
Otud7a |
OTU domain containing 7A |
1414 |
0.41 |
chr12_12581338_12581528 | 5.35 |
AC107703.1 |
novel transcript |
88484 |
0.08 |
chr5_35447766_35447917 | 5.34 |
Gm43377 |
predicted gene 43377 |
51743 |
0.09 |
chr10_126680401_126680552 | 5.34 |
Gm40797 |
predicted gene, 40797 |
16478 |
0.16 |
chr16_78238212_78238715 | 5.32 |
Gm25916 |
predicted gene, 25916 |
1795 |
0.31 |
chr15_91018414_91018934 | 5.30 |
Kif21a |
kinesin family member 21A |
31144 |
0.16 |
chr17_15194885_15195499 | 5.30 |
Gm35455 |
predicted gene, 35455 |
43033 |
0.12 |
chr1_6733683_6734408 | 5.29 |
St18 |
suppression of tumorigenicity 18 |
825 |
0.73 |
chr3_5356345_5356496 | 5.27 |
Zfhx4 |
zinc finger homeodomain 4 |
114748 |
0.06 |
chr4_63166503_63166666 | 5.27 |
Kif12 |
kinesin family member 12 |
5146 |
0.18 |
chr6_6997640_6997829 | 5.27 |
Sdhaf3 |
succinate dehydrogenase complex assembly factor 3 |
41727 |
0.13 |
chr3_66102086_66102567 | 5.21 |
Gm36973 |
predicted gene, 36973 |
2521 |
0.19 |
chr12_107758502_107758741 | 5.21 |
4930465M20Rik |
RIKEN cDNA 4930465M20 gene |
23125 |
0.21 |
chr2_66171763_66171914 | 5.20 |
Gm13618 |
predicted gene 13618 |
15998 |
0.16 |
chr9_78881002_78881173 | 5.19 |
Gm47498 |
predicted gene, 47498 |
55696 |
0.11 |
chr5_103917140_103917291 | 5.17 |
Klhl8 |
kelch-like 8 |
5956 |
0.16 |
chr4_87648042_87648964 | 5.15 |
Gm12604 |
predicted gene 12604 |
67714 |
0.13 |
chr9_41697271_41698297 | 5.09 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr13_34239148_34239326 | 5.05 |
Slc22a23 |
solute carrier family 22, member 23 |
45706 |
0.11 |
chr12_12581649_12581893 | 5.04 |
AC107703.1 |
novel transcript |
88146 |
0.08 |
chr10_54939520_54939728 | 4.99 |
Gm31849 |
predicted gene, 31849 |
117569 |
0.07 |
chr1_112379892_112380215 | 4.97 |
Gm18406 |
predicted gene, 18406 |
24802 |
0.25 |
chr5_128684660_128684818 | 4.94 |
Piwil1 |
piwi-like RNA-mediated gene silencing 1 |
17785 |
0.17 |
chr9_16599376_16599574 | 4.94 |
Fat3 |
FAT atypical cadherin 3 |
98190 |
0.09 |
chr13_78209758_78209944 | 4.93 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
7064 |
0.14 |
chr12_99011149_99011587 | 4.93 |
Gm47109 |
predicted gene, 47109 |
18359 |
0.16 |
chr9_16599178_16599357 | 4.91 |
Fat3 |
FAT atypical cadherin 3 |
97982 |
0.09 |
chr12_90132985_90133136 | 4.90 |
Gm48700 |
predicted gene, 48700 |
64961 |
0.14 |
chr1_74797413_74797875 | 4.88 |
Wnt10a |
wingless-type MMTV integration site family, member 10A |
4281 |
0.13 |
chr10_3819373_3819584 | 4.88 |
Plekhg1 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
15401 |
0.22 |
chr4_105190955_105191147 | 4.88 |
Plpp3 |
phospholipid phosphatase 3 |
33704 |
0.21 |
chr3_93014341_93014882 | 4.86 |
Crct1 |
cysteine-rich C-terminal 1 |
1058 |
0.33 |
chr5_37895375_37895742 | 4.85 |
Gm20052 |
predicted gene, 20052 |
851 |
0.66 |
chr2_45158345_45158770 | 4.83 |
Gm28643 |
predicted gene 28643 |
1632 |
0.43 |
chr15_22578403_22578554 | 4.81 |
Cdh18 |
cadherin 18 |
29456 |
0.25 |
chr1_176880148_176880453 | 4.80 |
Gm25993 |
predicted gene, 25993 |
466 |
0.65 |
chr12_112412078_112412242 | 4.80 |
A730018C14Rik |
RIKEN cDNA A730018C14 gene |
2767 |
0.21 |
chr2_69050143_69050294 | 4.80 |
Gm38377 |
predicted gene, 38377 |
32122 |
0.13 |
chr3_81535915_81536075 | 4.79 |
Gm4857 |
predicted gene 4857 |
20830 |
0.26 |
chr8_88604116_88604818 | 4.79 |
Nkd1 |
naked cuticle 1 |
21662 |
0.15 |
chr16_46769423_46769582 | 4.79 |
Gm17900 |
predicted gene, 17900 |
231667 |
0.02 |
chr12_64692515_64692674 | 4.75 |
Gm24066 |
predicted gene, 24066 |
43808 |
0.17 |
chr7_92025050_92025207 | 4.75 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
37266 |
0.15 |
chr15_98001311_98001664 | 4.74 |
Col2a1 |
collagen, type II, alpha 1 |
400 |
0.82 |
chr14_8430713_8430870 | 4.74 |
Gm8416 |
predicted gene 8416 |
21874 |
0.19 |
chr5_147315601_147315782 | 4.72 |
Urad |
ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5) decarboxylase |
6749 |
0.11 |
chr4_5962884_5963179 | 4.69 |
Gm11797 |
predicted gene 11797 |
106843 |
0.07 |
chr13_77263504_77263655 | 4.69 |
2210408I21Rik |
RIKEN cDNA 2210408I21 gene |
70545 |
0.12 |
chr4_122831887_122832046 | 4.68 |
Ppt1 |
palmitoyl-protein thioesterase 1 |
4276 |
0.2 |
chr5_111113715_111114064 | 4.65 |
Gm43677 |
predicted gene 43677 |
44422 |
0.13 |
chr12_108320572_108321271 | 4.62 |
4930478K11Rik |
RIKEN cDNA 4930478K11 gene |
7109 |
0.16 |
chr1_4538420_4538580 | 4.61 |
Gm38076 |
predicted gene, 38076 |
3214 |
0.17 |
chr7_76560879_76561212 | 4.61 |
2310001K20Rik |
RIKEN cDNA 2310001K20 gene |
50020 |
0.18 |
chr14_122406594_122407313 | 4.60 |
Gm5089 |
predicted gene 5089 |
210 |
0.93 |
chr16_45723681_45724070 | 4.59 |
Tagln3 |
transgelin 3 |
733 |
0.58 |
chr13_84639067_84639248 | 4.59 |
Gm26913 |
predicted gene, 26913 |
51784 |
0.18 |
chr10_126620084_126620246 | 4.57 |
Gm47965 |
predicted gene, 47965 |
33361 |
0.16 |
chr11_89301570_89301780 | 4.57 |
Nog |
noggin |
657 |
0.59 |
chr7_75983169_75983876 | 4.57 |
Gm45139 |
predicted gene 45139 |
17302 |
0.24 |
chr5_77838512_77838806 | 4.56 |
Gm42673 |
predicted gene 42673 |
70801 |
0.12 |
chr12_33592468_33592619 | 4.56 |
Gm9368 |
predicted gene 9368 |
95646 |
0.07 |
chr16_31591617_31592314 | 4.55 |
Gm34256 |
predicted gene, 34256 |
1255 |
0.43 |
chr12_118530084_118530282 | 4.55 |
D230030E09Rik |
Riken cDNA D230030E09 gene |
10 |
0.98 |
chr18_55763810_55763961 | 4.54 |
Gm26959 |
predicted gene, 26959 |
17657 |
0.23 |
chr2_172345010_172346316 | 4.53 |
Fam210b |
family with sequence similarity 210, member B |
98 |
0.95 |
chr3_4280464_4280840 | 4.52 |
Gm23976 |
predicted gene, 23976 |
24641 |
0.19 |
chr18_59062171_59062581 | 4.51 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
86 |
0.98 |
chr12_55927001_55927152 | 4.50 |
Gm22296 |
predicted gene, 22296 |
16153 |
0.2 |
chr15_31223650_31224072 | 4.50 |
Dap |
death-associated protein |
453 |
0.82 |
chr14_21991208_21991607 | 4.50 |
C130012C08Rik |
RIKEN cDNA C130012C08 gene |
1029 |
0.4 |
chr8_15670950_15671128 | 4.50 |
Gm45675 |
predicted gene 45675 |
41058 |
0.16 |
chr2_124601769_124602347 | 4.49 |
Sema6d |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
8048 |
0.31 |
chr14_98073671_98073874 | 4.48 |
Gm16331 |
predicted gene 16331 |
44737 |
0.18 |
chr1_137373621_137374166 | 4.48 |
Gm23534 |
predicted gene, 23534 |
6646 |
0.26 |
chr3_154817087_154817287 | 4.47 |
Gm18589 |
predicted gene, 18589 |
22420 |
0.2 |
chr15_64043955_64044229 | 4.47 |
Fam49b |
family with sequence similarity 49, member B |
16238 |
0.16 |
chr1_78364582_78364733 | 4.46 |
Gm37884 |
predicted gene, 37884 |
10957 |
0.18 |
chr7_79507353_79507621 | 4.45 |
Mir9-3 |
microRNA 9-3 |
2223 |
0.14 |
chr4_66025392_66025654 | 4.45 |
Gm11484 |
predicted gene 11484 |
328326 |
0.01 |
chr2_144101467_144101676 | 4.44 |
Banf2os |
barrier to autointegration factor 2, opposite strand |
32765 |
0.13 |
chr2_43583459_43583610 | 4.44 |
Kynu |
kynureninase |
16081 |
0.27 |
chr16_46291576_46291727 | 4.42 |
Gm26297 |
predicted gene, 26297 |
71815 |
0.11 |
chr2_14535423_14535658 | 4.42 |
Gm13266 |
predicted gene 13266 |
22941 |
0.16 |
chr10_116018524_116018900 | 4.42 |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
425 |
0.9 |
chr17_43504659_43504858 | 4.40 |
Mep1a |
meprin 1 alpha |
1946 |
0.32 |
chr9_50191284_50191435 | 4.39 |
Gm8907 |
predicted gene 8907 |
4314 |
0.23 |
chr16_73096919_73097070 | 4.39 |
4930500H12Rik |
RIKEN cDNA 4930500H12 gene |
1913 |
0.49 |
chr13_81037442_81037597 | 4.38 |
Gm4813 |
predicted gene 4813 |
7618 |
0.12 |
chr3_63412374_63412525 | 4.37 |
Gm34240 |
predicted gene, 34240 |
26802 |
0.19 |
chr14_14349400_14349589 | 4.36 |
Il3ra |
interleukin 3 receptor, alpha chain |
127 |
0.93 |
chr15_41155438_41155783 | 4.35 |
4930555K19Rik |
RIKEN cDNA 4930555K19 gene |
17877 |
0.26 |
chr3_79818299_79818691 | 4.35 |
Gm26420 |
predicted gene, 26420 |
16438 |
0.17 |
chr4_142239299_142240110 | 4.35 |
Kazn |
kazrin, periplakin interacting protein |
303 |
0.92 |
chr15_8626514_8626665 | 4.34 |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
16658 |
0.18 |
chr5_88583730_88583896 | 4.34 |
Rufy3 |
RUN and FYVE domain containing 3 |
19 |
0.97 |
chr9_37432079_37432230 | 4.34 |
Robo3 |
roundabout guidance receptor 3 |
1092 |
0.39 |
chr1_179458405_179458561 | 4.33 |
Smyd3 |
SET and MYND domain containing 3 |
53064 |
0.12 |
chr5_131602014_131602198 | 4.32 |
Gm42589 |
predicted gene 42589 |
3298 |
0.15 |
chr3_56438582_56438733 | 4.32 |
Gm25727 |
predicted gene, 25727 |
6755 |
0.33 |
chr17_75102139_75102290 | 4.31 |
Gm6276 |
predicted pseudogene 6276 |
62993 |
0.12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.8 | 5.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.8 | 5.4 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
1.7 | 5.2 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.5 | 5.9 | GO:0060594 | mammary gland specification(GO:0060594) |
1.4 | 4.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.4 | 11.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
1.4 | 5.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.4 | 4.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.3 | 5.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.2 | 4.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.2 | 3.7 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.2 | 5.9 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
1.2 | 5.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.2 | 3.5 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
1.2 | 3.5 | GO:0072069 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
1.2 | 3.5 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.1 | 6.9 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.1 | 3.4 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.1 | 3.3 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.1 | 8.8 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
1.1 | 3.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.1 | 6.4 | GO:0097264 | self proteolysis(GO:0097264) |
1.0 | 5.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.0 | 2.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.0 | 10.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.9 | 3.8 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.9 | 0.9 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.9 | 3.7 | GO:0007412 | axon target recognition(GO:0007412) |
0.9 | 3.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.9 | 2.7 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.9 | 2.7 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.9 | 3.5 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.9 | 2.6 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.9 | 0.9 | GO:0072197 | ureter morphogenesis(GO:0072197) |
0.9 | 1.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.8 | 5.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.8 | 3.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.8 | 3.3 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.8 | 2.5 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.8 | 2.5 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.8 | 3.3 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.8 | 4.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.8 | 2.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.8 | 2.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.8 | 1.5 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.8 | 2.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.8 | 2.3 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.7 | 3.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.7 | 2.2 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.7 | 17.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.7 | 2.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.7 | 2.8 | GO:0060174 | limb bud formation(GO:0060174) |
0.7 | 2.8 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.7 | 2.8 | GO:0030035 | microspike assembly(GO:0030035) |
0.7 | 1.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.7 | 0.7 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.7 | 3.4 | GO:1904970 | brush border assembly(GO:1904970) |
0.7 | 2.0 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.7 | 0.7 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.7 | 4.6 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.7 | 2.0 | GO:0030421 | defecation(GO:0030421) |
0.6 | 1.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.6 | 1.9 | GO:0030070 | insulin processing(GO:0030070) |
0.6 | 3.8 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.6 | 4.9 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.6 | 6.7 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.6 | 1.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.6 | 2.4 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.6 | 1.8 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.6 | 2.3 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.6 | 1.7 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.6 | 7.4 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.6 | 4.0 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.6 | 1.7 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.6 | 2.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.6 | 1.7 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.6 | 1.7 | GO:0015889 | cobalamin transport(GO:0015889) |
0.6 | 1.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.6 | 1.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.5 | 2.7 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.5 | 1.6 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.5 | 2.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.5 | 2.1 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.5 | 1.6 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.5 | 1.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.5 | 3.7 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 1.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.5 | 0.5 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.5 | 1.5 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.5 | 2.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.5 | 1.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.5 | 1.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.5 | 1.4 | GO:0097503 | sialylation(GO:0097503) |
0.5 | 1.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.5 | 2.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 1.4 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.5 | 3.3 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.5 | 0.9 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.5 | 2.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.5 | 0.9 | GO:0021564 | vagus nerve development(GO:0021564) |
0.5 | 3.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.5 | 1.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.5 | 1.8 | GO:0050957 | equilibrioception(GO:0050957) |
0.5 | 1.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.5 | 2.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.5 | 6.8 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.5 | 1.4 | GO:0048840 | otolith development(GO:0048840) |
0.5 | 1.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.4 | 0.9 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.4 | 0.4 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) kidney smooth muscle tissue development(GO:0072194) |
0.4 | 1.3 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.4 | 2.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.4 | 0.4 | GO:0048880 | sensory system development(GO:0048880) |
0.4 | 1.7 | GO:0061743 | motor learning(GO:0061743) |
0.4 | 0.4 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.4 | 1.7 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 1.3 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.4 | 0.4 | GO:0060437 | lung growth(GO:0060437) |
0.4 | 0.8 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.4 | 2.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 0.8 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.4 | 0.8 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.4 | 0.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.4 | 32.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.4 | 2.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.4 | 1.2 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.4 | 1.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.4 | 2.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 0.8 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.4 | 0.4 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
0.4 | 1.2 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.4 | 1.2 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.4 | 1.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.4 | 1.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.4 | 1.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.4 | 3.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.4 | 0.8 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.4 | 0.8 | GO:0050955 | thermoception(GO:0050955) |
0.4 | 0.8 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.4 | 1.9 | GO:0071372 | response to follicle-stimulating hormone(GO:0032354) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.4 | 3.0 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.4 | 1.9 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.4 | 0.4 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.4 | 0.4 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.4 | 1.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 1.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 1.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 1.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.4 | 1.1 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.4 | 0.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.4 | 0.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 2.5 | GO:0070141 | response to UV-A(GO:0070141) |
0.4 | 1.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.4 | 0.4 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.4 | 0.4 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.4 | 1.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 1.1 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.3 | 0.3 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.3 | 0.7 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.3 | 1.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 1.7 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.3 | 1.0 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 1.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.3 | 3.1 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.3 | 15.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 1.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 6.0 | GO:0001964 | startle response(GO:0001964) |
0.3 | 0.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.3 | 1.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 1.3 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.3 | 0.7 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.3 | 0.7 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.3 | 1.3 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.3 | 1.0 | GO:0021586 | pons maturation(GO:0021586) |
0.3 | 0.6 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.3 | 5.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 0.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 1.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.3 | 1.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 1.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.3 | 2.5 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.3 | 6.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.3 | 1.8 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.3 | 0.6 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.3 | 2.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 0.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 0.9 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.3 | 0.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.3 | 1.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.3 | 0.9 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.3 | 1.5 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.3 | 0.3 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.3 | 0.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 1.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 1.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 0.8 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.3 | 0.6 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.3 | 2.0 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 1.1 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.3 | 2.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.3 | 0.8 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 0.5 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.3 | 1.1 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 1.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.3 | 0.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.3 | 0.8 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 1.3 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.3 | 0.8 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.3 | 0.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 2.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 0.8 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 | 0.5 | GO:0008355 | olfactory learning(GO:0008355) |
0.3 | 1.0 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.3 | 0.8 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.3 | 0.5 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.3 | 1.3 | GO:0007567 | parturition(GO:0007567) |
0.3 | 0.8 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 0.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.3 | 0.8 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.3 | 0.5 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.3 | 1.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.3 | 0.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 1.8 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.3 | 0.8 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.3 | 0.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.2 | 1.7 | GO:0071625 | vocalization behavior(GO:0071625) |
0.2 | 0.2 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.2 | 0.2 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.2 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.7 | GO:1903288 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.2 | 2.4 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.2 | 1.0 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.2 | 2.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 1.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.5 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.7 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.2 | 0.2 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.2 | 0.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 0.5 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.7 | GO:1902896 | terminal web assembly(GO:1902896) |
0.2 | 0.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 3.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 3.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.7 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.2 | 0.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 4.3 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.2 | 0.4 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.9 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 0.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.7 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 0.7 | GO:0098597 | observational learning(GO:0098597) |
0.2 | 0.7 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 0.7 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.2 | 0.7 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 2.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 0.4 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.2 | 0.4 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.2 | 3.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 0.6 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.8 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.2 | 0.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.2 | 0.6 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.2 | 0.8 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.2 | 0.6 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 0.8 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 0.6 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 0.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.2 | 0.2 | GO:0060435 | bronchiole development(GO:0060435) |
0.2 | 0.8 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 0.8 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 0.4 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.2 | 1.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 0.2 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 0.4 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.2 | 1.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.2 | 0.8 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 2.5 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 2.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 1.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 1.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 1.9 | GO:0060914 | heart formation(GO:0060914) |
0.2 | 1.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 1.9 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 1.3 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.2 | 0.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.4 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 1.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 0.5 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.2 | 0.5 | GO:0070668 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.2 | 0.9 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 0.4 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.2 | 0.5 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.2 | 0.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 0.2 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.2 | 2.7 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 0.9 | GO:0060539 | diaphragm development(GO:0060539) |
0.2 | 0.4 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 0.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.7 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.2 | 0.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.2 | 0.2 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.2 | 1.0 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.2 | 0.5 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 0.7 | GO:0008354 | germ cell migration(GO:0008354) |
0.2 | 0.2 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 1.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 0.5 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.2 | 0.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 1.5 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.2 | 0.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 1.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 0.5 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.2 | 0.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.2 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.2 | 0.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 0.7 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.2 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.3 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 0.7 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.2 | 0.3 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 0.7 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 1.0 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.2 | 0.8 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 1.6 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.2 | 1.0 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 1.8 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.2 | 0.6 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 1.0 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.2 | 0.6 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.2 | 2.6 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 1.7 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.2 | 0.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 1.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.6 | GO:0046618 | drug export(GO:0046618) |
0.2 | 0.5 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.2 | 0.2 | GO:0042504 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.2 | 0.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 0.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.3 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 0.3 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.2 | 0.3 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.2 | 0.5 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.2 | 2.0 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.2 | 0.6 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 0.8 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.5 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.2 | 0.3 | GO:1903423 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.2 | 2.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 1.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 1.3 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.1 | 0.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.7 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.6 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 1.4 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.1 | 1.7 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.1 | 0.7 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 1.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.4 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.4 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.4 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.1 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 0.1 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.8 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.3 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.1 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.1 | 0.4 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.3 | GO:0099612 | protein localization to axon(GO:0099612) |
0.1 | 0.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.1 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 0.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.3 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.4 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.8 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 0.4 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 1.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 4.8 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.1 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.4 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.9 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.2 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.5 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.6 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 0.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.6 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.2 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.1 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 1.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.7 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 0.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.3 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.6 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.3 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.1 | GO:0001705 | ectoderm formation(GO:0001705) |
0.1 | 0.3 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.1 | 0.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.2 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.2 | GO:0019230 | proprioception(GO:0019230) |
0.1 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.4 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.1 | 0.1 | GO:0072298 | regulation of metanephric glomerulus development(GO:0072298) |
0.1 | 3.1 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 2.6 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 0.8 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.7 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 1.3 | GO:1902572 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.4 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.2 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.1 | 0.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.1 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
0.1 | 0.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 1.2 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.4 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.1 | 1.2 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 1.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.4 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.4 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.2 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.1 | 0.2 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.4 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 2.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.1 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.1 | 0.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.1 | 0.3 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.3 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.1 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) |
0.1 | 0.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.1 | 0.4 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 0.1 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.3 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.3 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.5 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.1 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.2 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.2 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.2 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.1 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.1 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 0.2 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.1 | 2.2 | GO:0003407 | neural retina development(GO:0003407) |
0.1 | 0.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 1.1 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.1 | 0.7 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 0.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 0.2 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.4 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.2 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.3 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.3 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 0.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.6 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.6 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.6 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.1 | 0.1 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.1 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.5 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.2 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.2 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.3 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.3 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.1 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.5 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.8 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.1 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.3 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.1 | 1.0 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.1 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.3 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.1 | 0.1 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.1 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.3 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.1 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 0.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.1 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.2 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.3 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.1 | 0.1 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) |
0.1 | 0.7 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.2 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.1 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.1 | 0.1 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.1 | 0.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.1 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.0 | 0.0 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 3.8 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.0 | 0.0 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.0 | 0.0 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.0 | 0.0 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.0 | 0.5 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.2 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.0 | 0.1 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.0 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 1.0 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.3 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.0 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.1 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.0 | 0.0 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.0 | 0.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.1 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.0 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.1 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.0 | 0.0 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.0 | 0.4 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.0 | GO:0003164 | His-Purkinje system development(GO:0003164) bundle of His development(GO:0003166) |
0.0 | 0.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.0 | 0.0 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.0 | 0.1 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.0 | 0.3 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.0 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 0.3 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.0 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.0 | 0.4 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.4 | GO:0050718 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.8 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.0 | 0.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.2 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.0 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.0 | 0.0 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) |
0.0 | 0.1 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.0 | 0.4 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.1 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.0 | 0.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.2 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.1 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.1 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.0 | 0.0 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.0 | 0.8 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.0 | 0.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.0 | 0.0 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.0 | 0.0 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.0 | 0.0 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.0 | 0.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.4 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.0 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.0 | 0.0 | GO:0021548 | pons development(GO:0021548) |
0.0 | 0.0 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.0 | 0.0 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.0 | 0.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.2 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.1 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.0 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.1 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.2 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.0 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.2 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.0 | 0.5 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.1 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.0 | 0.1 | GO:1904478 | regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
0.0 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.0 | 0.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.0 | 0.0 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.0 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 0.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.0 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.0 | 0.0 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.1 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.0 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.0 | 0.3 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.0 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.0 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.0 | 0.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.0 | 0.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.0 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0072431 | signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.0 | 0.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.0 | GO:0046959 | habituation(GO:0046959) |
0.0 | 0.0 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.0 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.0 | 0.0 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.0 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.0 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.0 | 0.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.0 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.0 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.0 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.0 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.0 | 0.0 | GO:0060911 | cardiac cell fate commitment(GO:0060911) |
0.0 | 0.0 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.0 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.0 | 0.0 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.0 | 0.0 | GO:0072239 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus vasculature development(GO:0072239) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.0 | 0.2 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.0 | 0.0 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.0 | 0.0 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.0 | GO:0010534 | regulation of activation of JAK2 kinase activity(GO:0010534) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.1 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.0 | 0.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.0 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.0 | 0.0 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.0 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.0 | 0.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.9 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.2 | 9.3 | GO:0043083 | synaptic cleft(GO:0043083) |
1.0 | 3.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.9 | 7.2 | GO:0071437 | invadopodium(GO:0071437) |
0.9 | 2.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.8 | 14.8 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.8 | 5.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.8 | 3.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.7 | 2.1 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.7 | 2.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.7 | 3.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.7 | 7.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.6 | 5.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.5 | 6.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.5 | 4.3 | GO:0016342 | catenin complex(GO:0016342) |
0.5 | 3.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.5 | 1.5 | GO:0042585 | germinal vesicle(GO:0042585) |
0.5 | 1.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 0.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.4 | 5.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 2.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.4 | 1.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 6.1 | GO:0031045 | dense core granule(GO:0031045) |
0.4 | 1.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.4 | 2.3 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.4 | 1.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.4 | 3.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.4 | 3.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 5.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 7.4 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 4.3 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 3.3 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 1.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 6.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 1.2 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 0.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.3 | 0.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 2.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 2.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 0.9 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 2.2 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 1.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 1.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 1.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.3 | 0.8 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 37.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 4.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 1.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 0.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 9.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 2.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 2.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 2.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 5.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 0.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 0.7 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 1.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 0.4 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 1.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 0.6 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 0.5 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 0.7 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 0.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 0.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 3.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 1.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 1.9 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.4 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.3 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.4 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 0.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 0.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 12.5 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 5.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 1.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.5 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 1.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.6 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 1.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 1.0 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 4.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.3 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.2 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 0.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.8 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.9 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.6 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 0.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.7 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.1 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 2.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.2 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.5 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.7 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.6 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.0 | 0.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.6 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.5 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.4 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.2 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.1 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.0 | 0.1 | GO:0030689 | Noc complex(GO:0030689) |
0.0 | 0.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.2 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.0 | 0.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 9.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.4 | 6.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.2 | 3.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.2 | 9.6 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.1 | 5.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.1 | 3.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.1 | 3.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.0 | 3.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.0 | 6.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.9 | 3.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.9 | 3.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.9 | 2.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.8 | 2.5 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.8 | 2.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.8 | 2.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.8 | 2.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.8 | 2.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.7 | 2.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.7 | 2.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.7 | 6.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.7 | 7.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.7 | 3.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.6 | 1.9 | GO:0070905 | serine binding(GO:0070905) |
0.6 | 2.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.6 | 3.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 1.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.6 | 4.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.6 | 1.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.6 | 1.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.6 | 2.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.6 | 1.7 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.6 | 1.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.6 | 2.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.5 | 1.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 5.9 | GO:0017065 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.5 | 11.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.5 | 1.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.5 | 3.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.5 | 1.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.5 | 1.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.5 | 3.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.5 | 1.9 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.4 | 2.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 3.0 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.4 | 1.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 1.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 2.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.4 | 1.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.4 | 0.8 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.4 | 1.2 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.4 | 1.2 | GO:0048030 | disaccharide binding(GO:0048030) |
0.4 | 1.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 2.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.4 | 1.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 1.5 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 2.5 | GO:0043495 | protein anchor(GO:0043495) |
0.4 | 1.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 1.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.4 | 7.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 1.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 3.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 1.0 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 1.0 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.3 | 5.9 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.3 | 1.0 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.3 | 1.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 1.0 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 1.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 2.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 1.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.3 | 1.2 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.3 | 1.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.3 | 0.9 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 2.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 1.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 1.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.3 | 1.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 2.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 0.8 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.3 | 3.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 0.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.3 | 0.8 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 3.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 0.8 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 1.6 | GO:0002054 | nucleobase binding(GO:0002054) |
0.3 | 5.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 4.1 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 0.7 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.2 | 0.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 1.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 4.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 5.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 2.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 1.1 | GO:0034865 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 2.0 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 1.8 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.2 | 1.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 0.7 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 1.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 0.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 1.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 1.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 0.6 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 0.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 0.2 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
0.2 | 1.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 2.0 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 2.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 0.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 0.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.2 | 0.6 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.2 | 0.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 1.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 0.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.9 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 0.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 0.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 1.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 5.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 0.9 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 1.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 1.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 0.8 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 2.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 0.2 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 2.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 0.5 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 1.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 0.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 0.5 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 0.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 0.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 0.2 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.1 | 3.3 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 1.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.3 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 4.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.9 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 0.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.3 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 4.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 3.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.1 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 0.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.7 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.4 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.7 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.5 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 2.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 2.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.5 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 0.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 2.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.4 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 1.5 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.7 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 2.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 3.5 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 3.4 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 1.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.1 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.1 | 0.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.4 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 2.8 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.1 | 0.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 1.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 1.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 1.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) cadmium ion binding(GO:0046870) |
0.1 | 0.4 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.3 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 0.3 | GO:0008948 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 0.5 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 1.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 1.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 1.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 3.0 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.1 | 0.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.5 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 1.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 1.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 3.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 1.8 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.1 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.2 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 1.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.2 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 15.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 1.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.1 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.1 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 1.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.6 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 1.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.4 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.5 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 1.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.2 | GO:0035276 | ethanol binding(GO:0035276) |
0.0 | 0.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 4.6 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.0 | 0.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.3 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 1.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 2.8 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.3 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.0 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.2 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.0 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 1.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 0.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.2 | GO:0016775 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.0 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.1 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 0.7 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.8 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.0 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.7 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.0 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.2 | GO:0031489 | myosin V binding(GO:0031489) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 12.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 4.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 11.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 7.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 0.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 4.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 5.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 3.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 2.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 2.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 4.9 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 3.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 2.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 5.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 2.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.5 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 2.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 3.0 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 1.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 10.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 14.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.2 | 1.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.6 | 1.3 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.5 | 1.0 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.5 | 5.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 5.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.4 | 6.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 7.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 3.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 0.9 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.3 | 2.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 4.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 3.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 6.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 11.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 2.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 0.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 2.8 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 2.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 2.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 3.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 8.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 4.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 1.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 9.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 2.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 2.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 2.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 0.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 2.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 5.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 0.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 2.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 0.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 0.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 1.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 4.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 3.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 0.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 2.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 3.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 3.6 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.1 | 10.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 1.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 1.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.1 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.1 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 1.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.2 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.1 | 0.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 0.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 1.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.2 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 0.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 1.2 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.2 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.0 | 0.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.2 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.0 | 0.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.0 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |